Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2026-01-17 @ 5:50 PM
Study NCT ID:
NCT02436668
Status:
COMPLETED
Last Update Posted:
2020-12-30
First Post:
2015-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
Sponsor:
Pharmacyclics LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2018-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-04
First Submit QC Date:
None
Study First Post Date:
2015-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-31
Results First Submit QC Date:
None
Results First Post Date:
2020-11-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-07
Last Update Post Date:
2020-12-30
Last Update Post Date Type:
ACTUAL